Regulus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.

About RGLS

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. 

CEO
Joseph P. Hagan
CEOJoseph P. Hagan
Employees
34
Employees34
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
34
Employees34

RGLS Key Statistics

Market cap
184.82M
Market cap184.82M
Price-Earnings ratio
-3.20
Price-Earnings ratio-3.20
Dividend yield
—
Dividend yield—
Average volume
917.12K
Average volume917.12K
High today
$2.90
High today$2.90
Low today
$2.45
Low today$2.45
Open price
$2.60
Open price$2.60
Volume
1.85M
Volume1.85M
52 Week high
$2.90
52 Week high$2.90
52 Week low
$0.8301
52 Week low$0.8301

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.